manuel macia heras (@mmacia25) 's Twitter Profile
manuel macia heras

@mmacia25

ID: 2465154321

calendar_today06-04-2014 15:56:31

15,15K Tweet

766 Takipçi

690 Takip Edilen

Orlando RPN (@orlandorpn) 's Twitter Profile Photo

TODO lo que un Urgenciólogo e Intensivista necesita saber sobre RABDOMIÓLISIS por Trauma (CRUSH 🌟) 🍖 Fisiopatología 🍖 Diagnóstico 🍖 Tratamiento Descárgalo gratis: healthmanagement.org/c/icu/issueart…

TODO lo que un Urgenciólogo e Intensivista necesita saber sobre RABDOMIÓLISIS por Trauma (CRUSH 🌟)

🍖 Fisiopatología
🍖 Diagnóstico
🍖 Tratamiento

Descárgalo gratis: healthmanagement.org/c/icu/issueart…
Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ #PrecisionMedicine is IMPORTANT in #Lupus, but PERSONALIZED medicine, - taking into account the personal socio-economic determinants & patient #vulnerabilities-, is even MORE IMPORTANT. Check our latest PAPER with Daniel G. Oliveira & Zoe from Lupus Europe at: sciencedirect.com/science/articl…

✅ #PrecisionMedicine is IMPORTANT in #Lupus, but PERSONALIZED medicine, - taking into account the personal socio-economic determinants &amp; patient #vulnerabilities-, is even MORE IMPORTANT. Check our latest PAPER with <a href="/G_O_Daniel/">Daniel G. Oliveira</a> &amp; Zoe from <a href="/LupusEurope/">Lupus Europe</a> at: sciencedirect.com/science/articl…
🎸 Rock History 🎸 (@historyrock_) 's Twitter Profile Photo

Rolling Stones legend Mick Jagger turns 82 today. Here are some of his best moments and things not everyone would do at his age. A thread 🧵

Jonathan Chávez (@jonathannefro) 's Twitter Profile Photo

Balcinrenona, el nuevo antagonista selectivo de mineralocorticoides (similar a finerenona) en combinación con iSGLT2, será probado en personas con enfermedad renal crónica G3bA3 (TFGe 42ml/min y albuminuria 583mg) En el diseño del ensayo clínico MIRO-CKD academic.oup.com/ndt/advance-ar…

Balcinrenona, el nuevo antagonista selectivo de mineralocorticoides (similar a finerenona) en combinación con iSGLT2, será probado en personas con enfermedad renal crónica G3bA3 (TFGe 42ml/min y albuminuria 583mg)

En el diseño del ensayo clínico MIRO-CKD

academic.oup.com/ndt/advance-ar…
Journal of Clinical Investigation (@jclinicalinvest) 's Twitter Profile Photo

ICYMI: Chemotaxis as a driver in immune privilege. O. Thaunat & team dissect the mechanisms of endothelial preservation during cellular rejection and identify mechanisms underlying graft vasculature immune privilege. jci.org/articles/view/…

Richi González Dávila (@richigdavila) 's Twitter Profile Photo

Hoy se estrena 'DRAŽEN' en Movistar Plus+ a las 21.20 horas. Por siempre el mejor. Pasen los años que pasen. Vengan los jugadores que vengan. Drazen Petrovic, mí único ídolo.

Hoy se estrena 'DRAŽEN' en <a href="/MovistarPlus/">Movistar Plus+</a> a las 21.20 horas.

Por siempre el mejor. Pasen los años que pasen. Vengan los jugadores que vengan.

Drazen Petrovic, mí único ídolo.
JAMA (@jama_current) 's Twitter Profile Photo

The 2025 GOLD report updates inhaled pharmacotherapy guidelines for stable #COPD, prioritizing eosinophil levels to tailor treatment and reduce symptoms and exacerbations. ja.ma/3IM19KM

The 2025 GOLD report updates inhaled pharmacotherapy guidelines for stable #COPD, prioritizing eosinophil levels to tailor treatment and reduce symptoms and exacerbations. 

ja.ma/3IM19KM
ASN Publications (@asnpublications) 's Twitter Profile Photo

In this #ASNJASN Innovator Corner article, John Daugirdas proposes an ancillary holographic no-touch control system to reduce the risk of touch contamination involving dialysis machine controls. Read more about this cutting-edge invention: kidney.pub/JASN0807

In this #ASNJASN Innovator Corner article, John Daugirdas proposes an ancillary holographic no-touch control system to reduce the risk of touch contamination involving dialysis machine controls. Read more about this cutting-edge invention: kidney.pub/JASN0807
manuel macia heras (@mmacia25) 's Twitter Profile Photo

Effects of Dapagliflozin on Health-Related Quality of Life... : Journal of the American Society of Nephrology journals.lww.com/jasn/abstract/…

ASN Publications (@asnpublications) 's Twitter Profile Photo

Patients with CKD may benefit from engaging with the arts. In this #ASNCJASN #Perspective, authors share reflections from two initiatives for patients to engage in the performing arts as a complementary approach in their CKD care. kidney.pub/CJASN0808

Patients with CKD may benefit from engaging with the arts. In this #ASNCJASN #Perspective, authors share reflections from two initiatives for patients to engage in the performing arts as a complementary approach in their CKD care. kidney.pub/CJASN0808
David Koch Jr. Glomerular Kidney Center (@cuimcglomcenter) 's Twitter Profile Photo

Happy Tuesday! Check out "Clinical Phenotypes and Renal Outcomes in PLA2R-Associated Membranous Nephropathy: A Multi-Center Cohort Study with Unsupervised Cluster Analysis" with Dr. Bomback and Dr. Wooden as coauthors pubmed.ncbi.nlm.nih.gov/40577236/

Happy Tuesday! Check out "Clinical Phenotypes and Renal Outcomes in PLA2R-Associated Membranous Nephropathy: A Multi-Center Cohort Study with Unsupervised Cluster Analysis" with Dr. Bomback and Dr. Wooden as coauthors pubmed.ncbi.nlm.nih.gov/40577236/
manuel macia heras (@mmacia25) 's Twitter Profile Photo

A current update of the development of Chimeric Antigen... : Current Opinion in Nephrology and Hypertension journals.lww.com/co-nephrolhype…